. 2019 Sep 24;57(10):e00547-19. doi: 10.1128/JCM.00547-19

TABLE 2.

Clinical and serologic information from children with positive conventional two-tiered testing and negative modified two-tiered testing (n = 12)^a

Suspected stage of Lyme disease	Age (yr)	Symptom duration ≤30 days	eIA		Band(s) (kDa)		Classification	Subcategory^b
Suspected stage of Lyme disease	Age (yr)	Symptom duration ≤30 days	WCS	C6	IgG	IgM	Classification	Subcategory^b
Early disseminated	8	N	1.21	0.73	58, 45, 41, 39, 28, 23, 18	23	PSR	PSR1
	9	Y	4.45	0.42	66, 45, 41, 23, 18	41, 23	FNM	FNM1
	11	Y	1.28	0.40	None	41, 23	PSC	PSC1
	13	Y	1.19	0.22	None	41, 23	PSC	PSC1
	15	Y	1.70	0.80	93, 58, 41, 39, 18	23	PSR	PSR2
	17	Y	1.12	0.32	93, 66, 45, 41, 23	None	PSR	PSR2

Late	3	Y	6.30	0.07	93, 66, 58, 45, 41, 39, 30, 28, 23, 18	41, 39, 23	PSR	PSR4
	3	Y	1.60	0.88	93, 66, 58, 41, 39, 23, 18	39, 23	FNM	FNM2
	14	Y	1.07	0.45	66	41, 23	PSR	PSR5
	15	N	2.04	0.80	58, 41, 39, 23, 18	None	PSR	PSR1
	15	Y	1.73	0.87	66, 58, 45, 41, 39, 23, 18	None	PSR	PSR3
	16	Y	1.06	0.66	66	41, 23	PSC	PSC1

PSC, partial seroconversion; PSR, partial seroreversion; FNM, false-negative MTTT.

See the the supplemental material for category descriptions.